EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Merck KGaA's enterprise value is $78,206 Mil.
Merck KGaA's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $6,141 Mil. Therefore, Merck KGaA's EV-to-EBITDA for today is 12.74.
The historical rank and industry rank for Merck KGaA's EV-to-EBITDA or its related term are showing as below:
MKKGY'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.96 Med: 12.86 Max: 19.27
Current: 12.75
During the past 13 years, the highest EV-to-EBITDA of Merck KGaA was 19.27. The lowest was 7.96. And the median was 12.86.
MKKGY's EV-to-EBITDA is ranked better than 53.81% of 708
companies
in the Drug Manufacturers industry
Industry Median: 14.075
vs MKKGY: 12.75
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-25), Merck KGaA's stock price is $32.07.
Merck KGaA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $1.398. Therefore, Merck KGaA's PE Ratio for today is 22.94.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Merck KGaA EV-to-EBITDA Historical Data
The historical data trend for Merck KGaA's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Merck KGaA's EV-to-EBITDA
For the Drug Manufacturers - Specialty & Generic subindustry, Merck KGaA's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Merck KGaA's EV-to-EBITDA Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Merck KGaA's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Merck KGaA's EV-to-EBITDA falls into.
Merck KGaA EV-to-EBITDA Calculation
Merck KGaA's EV-to-EBITDA for today is calculated as:
Merck KGaA's current Enterprise Value is $78,206 Mil.
Merck KGaA's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $6,141 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Merck KGaA (OTCPK:MKKGY) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Merck KGaA's share price for today is $32.07.
Merck KGaA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.398.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Merck KGaA's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Merck KGaA operates in three main segments: life sciences, performance materials, and healthcare. The life sciences segment (47% of 2022 sales) primarily provides laboratory consumables and services to researchers in academia and applied fields, including the biopharmaceutical industry. In the healthcare segment (35%), Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In its electronics segment (18%), the company offers specialty materials to manufacture a variety of products, such as semiconductors, flat-screen televisions, automobiles, and cosmetics. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MKKGY has been successfully added to your 